Paper published in a journal (Scientific congresses and symposiums)
Ptcy Prevents Xenogeneic Gvhd without Abrogating Gvl Effects
Ritacco, Caroline; Ehx, Grégory; Canti, Lorenzo et al.
2020In Biology of Blood and Marrow Transplantation, 26 (3), p. 168
Peer Reviewed verified by ORBi
 

Files


Full Text
PIIS1083879119308900.pdf
Publisher postprint (178.01 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Background Post-transplant administration of high-dose cyclophosphamide (PTCy) is one of the most efficient way to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (allo-HCT). However, the impact of PTCy on immune-mediated graft-versus-leukemia (GvL) effects has remained debated. Here, we investigated the impact of PTCy administration on xenogeneic GVHD and allogeneic GvL effects in two humanized mouse models. Impact of PTCy on xGVHD A single i.p. injection of cyclophosphamide (100 mg/kg) 3 days after infusion of 2 × 107 human PBMC in NSG mice significantly delayed xGVHD (64 vs 43 days, P < 0.0001). However, xGVHD was not abrogated and the majority of treated mice eventually succumbed from xGVHD. On day 21 after PBMC infusion, (human) blood T-cell counts were significantly lower in PTCy than in control mice (P = 0.0028) while the proportions of KI67+ CD4+ and CD4+ T cells were similar. Interestingly, at that time point the frequency of Treg in the blood was significantly higher in PTCy than in control mice (12.9 vs 4.3 %, P = 0.03). In further analyses, we compared human cells recovered from mouse blood and organs on day 6 after PBMC infusion (60 hours after PTCy in PTCy-treated mice). In comparison to untreated mice, PTCy mice had a dramatically lower proportion of KI67+ T cells as well as a much higher proportion of CD4+ apoptotic T cells. Treg numbers in the peripheral blood were also significantly lower in PTCy than in control mice. Looking at the bone marrow and other xGVHD target organs, PTCy-treated mice had a lower proportion of proliferative (i.e. KI67+) CD4+ T cells as well as of proliferative Tregs. Impact of PTCy on GvL effects The impact of PTCy on GvL effects was assessed in NSG-HLA-A2/HHD mice (a strain of NSG mice that express in addition to mouse MHC, the human HLA-A0201). All mice were i.v. injected with the human (HLA-A0201) AML cell line THP-1 transfected with the luciferase gene on day 0, while a second injection of THP-1 cells was administered on day 5. Four groups of mice were compared, a group of mice given only THP-1 cells, a second group given THP-1 cells and PTCy on day 3, a third group given THP-1 cells and human PBMC from a non HLA-A2 donor, and a last group of mice given THP-1 cells, PTCy and human PBMC from the same non HLA-A2 donor. On day 34, none of the THP-1+ PBMC mice had detectable tumors while THP-1 + PTCy + PBMC mice had detectable tumors but to a lesser extent that THP-1 only mice or THP-1+PTCy mice. The best survival was observed in THP-1+PTCy+PBMC mice while THP-1+PBMC mice died from xGVHD whereas THP-1+PTCy as well as THP-1 mice died from leukemia. Conclusions These results suggest that PTCy prevents xGVHD by depleting proliferative T cells and favoring the recovery of Treg. Further, GvL effects (although decreased) were not abrogated by PTCy.
Disciplines :
Hematology
Author, co-author :
Ritacco, Caroline ;  Université de Liège - ULiège > GIGA I3 - Hematology
Ehx, Grégory  ;  Université de Liège - ULiège > GIGA I3 - Hematology
Canti, Lorenzo  ;  Université de Liège - ULiège > GIGA I3 - Hematology
DUBOIS, Sophie ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'hématologie clinique
Vandenhove, Benoît ;  Université de Liège - ULiège > GIGA I3 - Hematology
SERVAIS, Sophie ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'hématologie clinique
Beguin, Yves  ;  Université de Liège - ULiège > Département des sciences cliniques > Hématologie
Baron, Frédéric  ;  Université de Liège - ULiège > GIGA I3 - Hematology
Language :
English
Title :
Ptcy Prevents Xenogeneic Gvhd without Abrogating Gvl Effects
Publication date :
01 March 2020
Event name :
2020 TCT Meetings of ASTCT and CIBMTR
Event place :
Orlando, United States
Event date :
19 - 23 February
Audience :
International
Journal title :
Biology of Blood and Marrow Transplantation
ISSN :
1083-8791
eISSN :
1523-6536
Publisher :
Elsevier, Netherlands
Volume :
26
Issue :
3
Pages :
168
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 24 September 2021

Statistics


Number of views
69 (20 by ULiège)
Number of downloads
8 (8 by ULiège)

OpenCitations
 
1

Bibliography


Similar publications



Contact ORBi